Emtricitabine Completed Phase 4 Trials for Acute HIV Infection / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00924898Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
NCT01102972A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
NCT02199613Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy
NCT02159599Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject
NCT00724711Safety and Efficacy Study of Switching From Epzicom to Truvada
NCT00244712Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
NCT01869634Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART
NCT03033836Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women
NCT00442962HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
NCT00084136Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
NCT00677300Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients
NCT00532168Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl
NCT00552240Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)
NCT00365612Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients
NCT00344760A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy
NCT00323492TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada
NCT00192634A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study
NCT00362687GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
NCT00414635FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
NCT00224445Boosted Atazanavir and Truvada Given Once-Daily - BATON Study
NCT00224458Combination of Efavirenz and Truvada - COMET Study
NCT00762892Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
NCT00615745ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla
NCT00615810ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
NCT00544128Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
NCT00106379Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients
NCT03502005Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1
NCT01234116Post-Exposure Prophylaxis in Health Care Workers
NCT00335322ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens
NCT01335620The Safety, Pharmacokinetic Profile and Efficacy of Raltegravir in HIV-infected Patients at Least 60 Years of Age
NCT00960622Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects
NCT01778413Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine
NCT00931801BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
NCT01270802Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients
NCT01694017Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy
NCT00757783Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment